Skip to main content
logo
TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
9.95
+0.19 (1.95%)
Jul 31, 2026, 4:08 PM HKT

HKG:2617 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
4,05945,604---
Market Cap Growth
-74.11%----
Enterprise Value
3,51644,908---
Last Close Price
9.95114.90---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
8.7698.42---
P/TBV Ratio
8.7798.52---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.000.000.010.010.00
Net Debt / Equity Ratio
-1.17-1.17-1.08-1.06-0.90
Net Debt / EBITDA Ratio
1.631.631.972.203.21
Net Debt / FCF Ratio
1.921.922.092.584.11
Asset Turnover
---0.00-
Quick Ratio
3.803.805.568.1810.15
Current Ratio
3.873.875.668.2411.98
Return on Equity (ROE)
-62.88%-62.88%-41.98%-36.63%-
Return on Assets (ROA)
-32.06%-32.06%-24.05%-23.02%-
Return on Capital Employed (ROCE)
-72.40%-72.40%-55.40%-48.80%-28.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-8.11%-0.72%---
FCF Yield
-6.96%-0.62%---
Buyback Yield / Dilution
-2.11%-2.11%-0.06%-5.83%-